Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Ligating Veins before Arteries Increases Surgery Survival Rates

By HospiMedica International staff writers
Posted on 28 May 2019
Tying off effluent veins before arteries during thoracoscopic lobectomy for lung cancer may reduce tumor-cell dissemination and thus increase survival, claims a new study.

Researchers at Sichuan University (Chengdu, China), Third Military Medical University (Chongqing, China), and other institutions conducted a study in 78 patients (74.4% older than 60 years) with non–small cell lung cancer who underwent thoracoscopic lobectomy. The aim of the study was to compare outcomes of different sequences of vessel ligation on the dissemination of tumor cells. The main outcomes and measures were changes in folate receptor–positive circulating tumor cells (FR+CTCs) after surgery, and 5-year overall, disease-free, and lung cancer–specific survival.

The results revealed that incremental changes in FR+CTCs were seen in 65% of the artery-first group, and in 31.6% in the vein-first group. While survival outcomes were not available because of the limited follow-up period, a retrospective analysis of the Western China Lung Cancer database (2005-2017) also found poorer survival with the artery-first procedure. At five years, the hazard ratio for poorer overall survival was 1.65, for disease-free survival it was 1.43, and for lung-cancer-specific survival, it was 1.65. The study was published on May 1, 2019, in JAMA Surgery.

“Numerous studies have demonstrated that surgical manipulation could promote the dissemination of tumor cells into the circulation. The vein-first approach eliminates repeated squeezes and turning over of the tumor bearing lobe during surgery,” concluded lead author Lunxu Liu, MD, of Sichuan University, and colleagues. “Ligating effluent veins first may reduce tumor cell dissemination and improve survival outcomes in patients with non-small cell lung cancer.”

“The explanation for the development of recurrent disease, especially distant metastases, in patients with completely resected pathologic early-stage lung cancer has eluded physicians for decades,” wrote Mark Ferguson, MD, of the University of Chicago (IL, USA), in an invited editorial. “Since 2015, spread of tumor through air spaces, a previously unrecognized phenomenon, has been accepted as a mechanism of tumor recurrence after lung resection. The study also suggests that additional surgical techniques aimed at avoiding release of tumor cells into the circulation should be explored.”

Related Links:
Sichuan University
Third Military Medical University


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Electrocardiograph
BeneHeart R700/R900
New
Prostate Cancer MRI Analysis Tool
DynaCAD Urology
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.